HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
TERN
Terns Pharmaceuticals Inc
Healthcare Biotechnology · California, USA · Reports in usd
Market Cap: $4.75B
Market Cap
$4.75B
Enterprise Val
$3.73B
P/E Ratio
-49.33
P/B Ratio
4.72
Trailing PEG (1Y)
-11.35
As Of
Apr 15, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$1.01B
Return on Equity-20.02%
Return on Assets-19.37%
Current Ratio62.41
Debt/Equity0.00
LT Debt/Equity0.00
Revenue Per Share0.00

Income Statement

Dec 31, 2025
Revenue$0.00
Cost of Revenue$0.00
Gross Profit$0.00
R&D$18.9M
SG&A$8.7M
Operating Expenses$27.6M
Operating Income-$27.6M
Interest Expense$0.00
Tax Expense$383.0K
Net Income-$23.6M
EPS (Basic)$-0.24
EPS (Diluted)$-0.24
EBIT-$23.2M
EBITDA-$23.1M
Consolidated Income-$23.6M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$524.7M
Accounts Receivable$0.00
Inventory$0.00
Current Assets$1.02B
LT Investments$0.00
Property, Plant & Equipment$884.0K
Intangibles$0.00
Non-Current Assets$884.0K
Total Assets$1.03B
Accounts Payable$1.7M
Current Debt$474.0K
Current Liabilities$16.4M
LT Debt$445.0K
Non-Current Liabilities$2.1M
Total Liabilities$18.6M
Total Debt$919.0K
Retained Earnings-$517.7M
Shareholder Equity$1.01B
Shares Outstanding90,079,781

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow-$19.1M
Investing Cash Flow-$350.0M
Financing Cash Flow$743.1M
CapEx$0.00
Free Cash Flow-$19.1M
Depreciation & Amort.$113.0K
Stock-Based Comp$3.4M
Acquisitions / Disposals$0.00
Investment Activity-$350.0M
Debt Issued/Repaid$0.00
Equity Issued/Repaid$743.3M
Dividends Paid$0.00
Net Change in Cash$374.0M
Data cached · Meta live · Daily live · Statements live · TTL 24h